Примери за използване на Symptomatic hypotension на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Symptomatic hypotension.
Patients at high risk of symptomatic hypotension, e.g.
Symptomatic hypotension could occur after initiation of treatment with Rasilamloin the following.
Concurrent use with alpha-adrenergic antagonist therapy may cause symptomatic hypotension;
Risk of symptomatic hypotension.
Consumption of alcohol in combination with avanafil can increase the potential for symptomatic hypotension.
As with all antihypertensive therapy, symptomatic hypotension may occur in some patients.
Symptomatic hypotension could occur after initiation of treatment with Rasilamlo in the following.
A sudden drop in blood pressure orheart rate, with or without symptomatic hypotension or bradycardia.
If symptomatic hypotension should occur, supportive treatment should be instituted and vital signs monitored.
Consumption of alcohol in combination with avanafil can increase the potential for symptomatic hypotension(see section 4.5).
Symptomatic hypotension could occur after initiation of treatment with Rasitrio in the following cases.
If such signs develop, with or without symptomatic hypotension or bradycardia, the infusion should be stopped immediately.
Based on pharmacological considerations,the main manifestation of an overdose is likely to be symptomatic hypotension and dizziness.
Treatment If symptomatic hypotension should occur with Rasitrio, supportive treatment should be initiated.
Based on pharmacological considerations,the main manifestation of an overdose is likely to be symptomatic hypotension and dizziness.
If symptomatic hypotension should occur, supportive treatment should be instituted and vital signs monitored.
Needle-related pain and/or anxiety have resulted in vasovagal responses,including transient symptomatic hypotension and syncope.
If symptomatic hypotension or renal dysfunction occur, consideration should be given to a dosage reduction.
In patients with heart failure, with or without associated renal insufficiency, symptomatic hypotension has been observed.
Symptomatic hypotension and/or hypovolaemia should be corrected before treatment with fentanyl transdermal patches is initiated.
Patients should avoid orlimit concurrent substantial ethanol consumption as this may increase the risk of symptomatic hypotension.
In patients at increased risk of symptomatic hypotension, initiation of therapy and dose adjustment should be closely monitored.
If symptomatic hypotension persists despite a decrease in LCZ696 powder(sacubitril/valsartan powder), the drug may need to be stopped.
The concomitant use of alpha-blockers andvardenafil may lead to symptomatic hypotension in some patients because both are vasodilators.
Symptomatic hypotension is more likely to occur if the patient has been volume-depleted, e.g. by diuretic therapy, dietary salt restriction, diarrhoea or vomiting.
Concomitant administration of sildenafil to patients taking alpha-blocker therapy may lead to symptomatic hypotension in susceptible individuals.
In patients at increased risk of symptomatic hypotension, initiation of therapy and dose adjustment should be closely monitored.
The incidence of adverse events did not show any association with gender,age(with the exception of symptomatic hypotension), body mass index, race or ethnicity.